Spike Pharmaceuticals set out to explore a new sales model
Release time:
2020-07-31
agent and terminal link production and chain cooperation
peak pharmaceutical industry began to explore a new sales model
news 8# October 16 to 21 , the 2017 China Pharmaceutical Retail Industry Information Conference (hereinafter referred to as "Xi Pu Conference") with the theme of "Building a Blueprint-Market Awakening Focusing on Demand" was held in Boao, Hainan. Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, and relevant responsible persons such as Jianfeng Health, Pharmaceutical Sales Company and Jianfeng Pharmacy were invited to attend the conference to create a new sales model "exploring way".
This year coincides with the 10th anniversary of the Western Conference. More than 20 1200 mainstream chain pharmacies, more than 22 800 brand pharmaceutical industries, more than 24 100 cross-border affiliated institutions, more than 26 130 top capital institutions at home and abroad, more than 28 60 representatives of authoritative media, and authoritative experts in the industry, nearly 30 4000 people gathered in Boao. The meeting combed the context of the pharmaceutical retail industry in the past ten years, discussed the development of the industry in the new decade, and built a new blueprint for the industry. During the meeting, Huang Jinlong led the peak participants to have in-depth exchanges with the leaders of the conference organizers and industry experts on the impact of national policies such as corporate brand strategy, the role of brand enterprises in the industry, medical reform, prescription outflow and other issues on the original sales model of pharmaceutical enterprises. He also had extensive contact with pharmaceutical counterparts and terminal chains, listened to front-line sales experience and collected relevant information on terminal chains, bring together the top 100 chain market dynamics. In the past ten years, the retail scale of drugs in China has increased from 1430
3377 .1 billion yuan, and the chain rate has increased from
to 49.4% , playing an increasingly important role in the self-medication and drug accessibility of the masses. With the trend of prescription outflow becoming clear, drug retail terminals are playing an increasingly important role in the national medical and health system, but the overall size of the top 100 retailers is still hovering around 34% of the total drug retail industry, which shows that there is still huge room for market concentration. Before the expected trillion-dollar market, Peak Pharmaceutical Sales Company set up a new sales control department, trying to further extend the original sales channels into the terminal chain market and explore new sales models. The relevant person in charge of Jianfeng Pharmaceutical said that in the current complex and changeable market environment, pharmaceutical sales have also given birth to many new models. The establishment of a sales control department is an attempt to seamlessly link the agent and terminal models., To more effectively grasp the terminal dynamics of the pharmaceutical market, to achieve the purpose of sorting out channels, controlling channels and terminals, and then to increase drug sales in a good market environment, to improve the core competitiveness of enterprises, more is to do the sustainable sales "growth" of products, build a brand system, create a 360 brand marketing promotion model, and open a new exploration of win-win cooperation with the terminal chain market. (Xu Yuting)
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page